Evidence map›Paper›PMID 35022519›Full record

ArticleCancer gene therapy2022

LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m

Chengpeng Zhao, Xiaoling Ling, Yunxia Xia, Bingxue Yan, Quanlin Guan

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer gene therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Methylation marks breast cancer metastasis: The roles of mThe Journal of biological chemistry · 2026
    Review
  3. Review
  4. Review
  5. Potential regulatory role of the mActa biochimica et biophysica Sinica · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Non-coding RNA-Mediated N6-Methyladenosine (mNon-coding RNA research · 2024
    Review
  18. Review
  19. Novel insights into mutual regulation between NCancer cell international · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chengpeng ZhaoDepartment of Internal Medicine-Oncology, The First Hospital of Lanzhou University, 730000, Lanzhou, P.R. China.
Xiaoling LingDepartment of Internal Medicine-Oncology, The First Hospital of Lanzhou University, 730000, Lanzhou, P.R. China.
Yunxia XiaThe First School of Clinical Medicine, Lanzhou University, 730000, Lanzhou, P.R. China.
Bingxue YanThe First School of Clinical Medicine, Lanzhou University, 730000, Lanzhou, P.R. China.
Quanlin GuanDepartment of Oncology Surgery, The First Hospital of Lanzhou University, 730000, Lanzhou, P.R. China. ldyy_zhaochp@lzu.edu.cn.ORCID http://orcid.org/0000-0002-9265-3767
First Hospital of Lanzhou University · CNLanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer, a multifactorial disease, represents one of the leading causes of cancer-related morbidity and mortality in women. This study set out to elucidate the underlying mechanism by which lncRNA UCA1 affects the m

Indexed as

Breast NeoplasmsMethyltransferasesMicroRNAsRNA, Long NoncodingSOXC Transcription FactorsCell ProliferationDNADNA MethylationFemaleGene Expression Regulation, NeoplasticHumansDNAMethyltransferasesMETTL14 protein, humanMicroRNAsMIRN375 microRNA, humanRNA, Long NoncodingSOX12 protein, humanSOXC Transcription FactorsUCA1 RNA, human

Identifiers

PMID35022519
OpenAlexW4205931508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.